Masimo Corporation
NASDAQ:MASIMedical - Devices
+$0.00 today
- Market cap
- $9.42B
- Beta
- 1.10
- P/E (TTM)
- 123.1
- EPS (TTM)
- $1.46
Volume 0.00M
Average 1.08M
MASI Operating Income
Profit from core operations after operating expenses, before interest and taxes.
Masimo CorporationNASDAQ: MASI
Operating Income · Q1 FY2026 · quarter ended Apr 2026
Operating income dips below year-ago levels
Q1 FY2026 operating income of $77.4M fell 0.8% year over year, behind the +248.0% change in trailing-twelve-month operating income. Sequentially, it fell 7.7% from the prior quarter. Over 3 fiscal years it compounded at +14.2% a year.
Context
- Operating income amounted to 20.5% of revenue in FY2025, up 7.8 pp from a year earlier.
- Operating income increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether operating income reaches the consensus estimate from 2 analysts of $153.76M (-50.8%) for the fiscal year ending Jan 2027, a slowdown from the +217.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterApr 2026
- $77.4M-7.7% QoQ
- Last fiscal yearJan 2026
- $312.8M+217.3% YoY
- LTMApr 2026
- $309.4M+248.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -0.8% | -41.7% | -40.9 pp |
| 1 year | +217.3% | -50.8% | -268.1 pp |
| 3-year CAGR | +14.2% | -17.1% | -31.3 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Income history
USD · from the income statement
- Latest · FY2025
- 312.8M USD
- Year-over-year change
- +217.3%
- 4-year CAGR
- +3.2%
| Period | Period end | Operating Income | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | 312.8M | +217.3% |
| FY2024 | 2024-12-28 | (266.7M) | -295.4% |
| FY2023 | 2023-12-31 | 136.5M | -35.0% |
| FY2022 | 2022-12-31 | 210M | -23.9% |
| FY2021 | 2021-12-31 | 275.8M | — |
Operating Income vs competitors
How MASI compares with its peers on the latest reported figures
- Peers report in different currencies, so operating income is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +248.0% is the 2nd highest of 11, against a peer median of -3.5%.
- Operating income amounts to 19.9% of revenue for MASI, versus a peer median of 8.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $774M USD | +0.0% | -6.9% | 5.7% | |
| LTM Jun 2026 | $486.55M USD | -6.4% | +10.5% | 12.4% | |
| LTM Apr 2026 | $309.4M USD | +248.0% | +14.2% | 19.9% | |
| LTM Jun 2026 | $235M USD | +5.1% | -17.6% | 9.1% | |
| LTM Jun 2026 | €196.53M EUR | +6.9% | -1.6% | 16.1% | |
| LTM Sep 2026 | $172M USD | -87.0% | -17.3% | 0.4% | |
| LTM Jun 2026 | $65.3M USD | +373.7% | -35.8% | 8.3% | |
| LTM Sep 2026 | -$187.25M USD | -0.6% | — | 66.7% | |
| FY2025 | -€246.06M EUR | -42.2% | — | — | |
| LTM Jun 2026 | -$274M USD | -783.9% | — | 2.4% | |
| LTM Jun 2026 | -$285.6M USD | -127.5% | — | 4.4% | |
| Peer median (excluding MASI) | — | -3.5% | -12.1% | 8.3% | |
Competitors are the stored peer set for MASI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 1.24B | 2.04B | 2.05B | 2.09B | 1.53B |
| Cost of Revenue | 430.8M | 977M | 1.04B | 1.09B | 581.7M |
| Gross Profit | 808.4M | 1.06B | 1B | 1B | 945.2M |
| Gross Margin | 65.2% | 52.0% | 49.0% | 48.0% | 61.9% |
| Research & Development | 137.2M | 191.4M | 175.2M | 222.8M | 126.4M |
| Selling, General & Admin | 395.4M | 657.4M | 664M | 743.8M | 506M |
| Operating Expenses | 532.6M | 848.8M | 867M | 1.27B | 632.4M |
| Depreciation & Amortization | 35.6M | 136.1M | 98.3M | 103M | 38.8M |
| EBITDA | 310.3M | 355.2M | 236.7M | (158.7M) | 344.6M |
| EBITDA Margin | 25.0% | 17.4% | 11.6% | -7.6% | 22.6% |
| Operating Income | 275.8M | 210M | 136.5M | (266.7M) | 312.8M |
| Operating Margin | 22.3% | 10.3% | 6.7% | -12.7% | 20.5% |
| Interest Income | 900K | 1.8M | 3M | 4.8M | 3.4M |
| Interest Expense | 300K | 25.7M | 50.3M | 43.6M | 33.2M |
| Other Income / Expenses | (1.4M) | (16.6M) | (48.4M) | (38.6M) | (40.2M) |
| Income Before Tax | 274.4M | 193.4M | 88.1M | (305.3M) | 272.6M |
| Pre-Tax Margin | 22.1% | 9.5% | 4.3% | -14.6% | 17.9% |
| Income Tax Expense | 44.8M | 49.9M | 6.6M | (400K) | 64.9M |
| Net Income | 229.6M | 143.5M | 81.5M | (304.9M) | (151.5M) |
| Net Margin | 18.5% | 7.0% | 4.0% | -14.6% | -9.9% |
| EPS (Basic) | 4.16 | 2.68 | 1.54 | (5.72) | (2.83) |
| EPS (Diluted) | 3.98 | 2.60 | 1.51 | (5.72) | (2.80) |
| Weighted Avg Shares | 55.17M | 53.6M | 52.8M | 53.3M | 53.6M |
| Weighted Avg Shares (Diluted) | 57.68M | 55.2M | 54.1M | 53.3M | 54.2M |
Masimo Corporation
NASDAQ:MASI
Intrinsic Alpha fair value
Locked
Current Price
$179.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.